bipolar%20disorder
BIPOLAR DISORDER
Bipolar I disorder is primarily defined by manic or mixed episodes that last for at least 7 days, or very severe manic symptoms needing immediate hospital care. The patient also has depressive episodes which may last for at least 2 weeks.
Bipolar II disorder is usually misdiagnosed. It is characterized by occurence of ≥1 major depressive episodes with at least 1 hypomanic episode.
Cyclothymic disorder or cyclothymia is a mild form of bipolar disorder. Patients have  episodes of hypomania alternating with mild depression that lasts for 2 years.
Rapid-cycling bipolar disorder patients have ≥4 episodes of major depression, mania, hypomania or mixed symptoms within a year.

Bipolar%20disorder Patient Education

Patient Education

General Recommendations

Patient and Family Education

  • Treatment plan needs to be discussed with both patient and family members
    • Discuss expected results, dosing strategies, side effects and drug interactions
  • They need to understand that long-term treatment is necessary
    • Education should continue throughout treatment
  • Educate patient and family about prodromal symptoms
    • Teach them to recognize early signs and symptoms of manic and depressive episodes and how to prevent
    • Patient may keep diary of events and moods over time to assist in this process
    • Teach them about destigmatization and non-discrimination
      • Specific strategies such as enhancing coping skills through improvements in self-esteem, empowerment and help-seeking behavior can help reduce stigma and can improve outcomes

Treatment Compliance

  • Encourage treatment compliance because noncompliance may lead to relapse
    • Must overcome patient’s ambivalence towards treatment
    • Patient may find mania/euphoric episode enjoyable hence fueling reluctance to medication

Manage Functional Impairment

  • Patients may suffer emotional, family, social, occupational, financial or academic problems during an episode
  • Full functional recovery rarely occurs within 12 weeks following the remission of mood symptoms
    • May need assistance in addressing the psychosocial consequences of their actions
    • Patient should be advised to withdraw from work or other responsibilities when needed
    • Major life decisions should not be done while in depressed, manic or hypomanic state

Psychosocial Stressors

  • Enhance coping strategy & problem solving skills in managing psychosocial stressors
  • Disruption in sleep cycles or social rhythm can trigger manic episodes
    • Disruption of sleep is usually the final common pathway trigerring manic episodes
    • Patient and family should be educated on the potential consequences and taught coping strategies
    • Patient may benefit from regular daily activity pattern, including eating, sleeping and physical activities along with emotional and social stimulation
  • Proper assessment, advice and treatment is required in managing patients who abuse substance/alcohol
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Audrey Abella, 6 days ago
A pilot telemedicine initiative may be an alternative for facilitating delivery of intravenous iron (IVI) for individuals requiring iron supplementation.